COMPASS Pathways (NASDAQ:CMPS – Get Free Report) is expected to be releasing its earnings data before the market opens on Thursday, February 27th. Analysts expect COMPASS Pathways to post earnings of ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, a ...
COMPASS Pathways (NASDAQ:CMPS – Free Report) had its price target reduced by HC Wainwright from $60.00 to $45.00 in a report ...
H.C. Wainwright analyst Patrick Trucchio revised the price target on Compass Pathways (NASDAQ:CMPS) stock, reducing it to $45 ...
Shares of Compass Pathways (NASDAQ:CMPS) lost ~35% in the premarket on Thursday after the psychedelic drug developer, with ...
H.C. Wainwright lowered the firm’s price target on Compass Pathways (CMPS) to $45 from $60 and keeps a Buy rating on the shares. The firm says ...
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on COMPASS Pathways (CMPS – Research Report) today and set a price target of ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.